These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3488193)

  • 41. Comparative in vitro activity of ciprofloxacin and other unrelated antimicrobials against bacterial respiratory tract pathogens.
    Felmingham D; Robbins MJ; Baskerville AJ; Sanghrajka MD; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1989; 15(2):59-62. PubMed ID: 2737080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
    Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H
    Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of the effect of antimicrobics in combination against Listeria monocytogenes.
    Meyer RD; Liu S
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):199-206. PubMed ID: 3105948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Microbiology in acute otitis media].
    Bingen E
    Rev Prat; 1998 Apr; 48(8):848-53. PubMed ID: 11767328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial susceptibility of Moraxella catarrhalis isolated from children in Kalgoorlie-Boulder, Western Australia.
    Pingault NM; Bowman JM; Lehmann D; Riley TV
    Pathology; 2010 Apr; 42(3):273-9. PubMed ID: 20350222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections.
    Slevin NJ; Aitken J; Thornley PE
    Lancet; 1984 Apr; 1(8380):782-3. PubMed ID: 6143094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
    Sader HS; Gales AC; Granacher TD; Pfaller MA; Jones RN;
    Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.
    Christensen JJ; Keiding J; Bruun B
    APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antibiotic sensitivity of Branhamella catarrhalis isolated from respiratory tract infections].
    Nishioka K; Ida S; Takishima T
    Jpn J Antibiot; 1984 Jul; 37(7):1289-93. PubMed ID: 6567671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S; Pellegrino MB; D'Amico G; Privitera A; Privitera O; Maccarrone G; Russo G; Nicoletti G
    Chemotherapy; 1992; 38(1):36-45. PubMed ID: 1618002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-vitro susceptibility of 400 isolates of Neisseria gonorrhoeae in Vancouver, 1982-84.
    Bowie WR; Shaw CE; Chan DG; Jones HD; Black WA
    CMAJ; 1986 Sep; 135(5):489-93. PubMed ID: 3091234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Moraxella (Branhamella) catarrhalis. A common pathogenic agent].
    Prost J; Scavizzi M
    Presse Med; 1993 May 1-8; 22(16):779-82. PubMed ID: 8316533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
    Tremblay LD; L'Ecuyer J; Provencher P; Bergeron MG
    CMAJ; 1990 Nov; 143(9):895-901. PubMed ID: 2224717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents.
    Doern GV; Tubert T
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1519-23. PubMed ID: 3124732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
    Eliasson I; Kamme C
    Drugs; 1986; 31 Suppl 3():116-21. PubMed ID: 3488190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.